SRX Global gets consent for $20M stock buyback

SRX Global obtained Required Holder consent so it can maintain a stock repurchase plan of up to $20 million or 10 million shares through July 7, 2027.

Rhea-AI Filing Summary

SRX Global Inc. (SRXH) reported that on September 8, 2026 it entered into a Limited Consent and Amendment Agreement with the Required Holders of its recently issued Series C convertible preferred stock. The consent relates to an existing stock repurchase plan for the company’s common stock.

Under this consent, the Required Holders agreed to consent to and waive certain rights so the company may maintain a stock repurchase plan allowing repurchases of up to the lesser of 10,000,000 shares of common stock or 50% of the issued and outstanding common stock at any given time, for an aggregate purchase price not to exceed $20,000,000, during the period ending July 7, 2027. The agreement follows the previously disclosed August 27, 2026 Securities Purchase Agreement under which accredited investors purchased 3,579 shares of Series C convertible preferred stock for $2.825 million.

Positive

• Consent agreement supports the company’s ability to maintain a stock repurchase plan of up to $20,000,000 or 10,000,000 shares, providing a structured framework for potential capital return through July 7, 2027.

Negative

• None.

Filing Explained

The September 8 filing reports holder consent for a repurchase plan, not repurchases themselves: the $20 million and share limits are maximum capacity through July 7, 2027, so this disclosure does not change the current common-share count.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Maximum shares under repurchase plan: 10,000,000 shares Repurchase plan dollar cap: $20,000,000 Repurchase plan period end: July 7, 2027 +3 more

6 metrics

Maximum shares under repurchase plan 10,000,000 shares Upper share limit for common stock repurchases, subject to also not exceeding 50% of issued and outstanding shares

Repurchase plan dollar cap $20,000,000 Aggregate purchase price limit for common stock repurchases through the period ending July 7, 2027

Repurchase plan period end July 7, 2027 Date through which the stock repurchase plan may be used under the consent agreement

Series C preferred shares sold 3,579 shares Number of Series C convertible preferred shares purchased by accredited investors on August 27, 2026

Series C preferred aggregate purchase price $2,825,000 Total consideration paid by accredited investors for Series C convertible preferred stock

Issued and outstanding percentage cap 50% Maximum proportion of issued and outstanding common stock that may be repurchased at any given time

Key Terms

Securities Purchase Agreement, Series C convertible preferred stock, Limited Consent and Amendment Agreement, Required Holders, +1 more

5 terms

Securities Purchase Agreement regulatory

"entered into a Securities Purchase Agreement with certain accredited investors"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

Series C convertible preferred stock financial

"purchased 3,579 shares of the Company’s Series C convertible preferred stock"

Series C convertible preferred stock is a class of investment shares issued in a later private financing round that combine safety and upside: they usually pay ahead of ordinary shares if a company pays dividends or is sold, but can be converted into common stock to share in future growth. For investors this acts like a VIP ticket with a safety net—offering priority protection while preserving the option to participate in a successful exit.

Limited Consent and Amendment Agreement regulatory

"entered into a Limited Consent and Amendment Agreement (the “Consent Agreement”)"

Required Holders financial

"the Company and the Required Holders entered into a Limited Consent"

stock repurchase plan financial

"the Company’s maintaining a stock repurchase plan under which the Company may repurchase"

A stock repurchase plan is a company’s program to buy back its own shares from the market, reducing the number of shares available to investors. Like a store buying back its own gift cards to raise the value of remaining cards, buybacks can increase each remaining share’s claim on profits and often signal management believes the stock is undervalued or is an efficient way to return cash, which can affect share price and investor returns.

FAQ

What agreement did SRXH announce on September 8, 2026?

SRX Global Inc. entered into a Limited Consent and Amendment Agreement with the Required Holders of its Series C preferred stock, providing consent and waivers needed for the company to maintain its common stock repurchase plan under specified limits and terms.

How large is SRXH’s authorized stock repurchase plan under the new consent?

The repurchase plan allows SRX Global to buy back up to the lesser of 10,000,000 common shares or 50% of its issued and outstanding common stock at any given time, with a total aggregate purchase price cap of $20,000,000.

Until when can SRXH repurchase shares under this plan?

SRX Global’s stock repurchase plan, as supported by the consent agreement, may be used during the period ending July 7, 2027, subject to the share and dollar limits defined in the agreement.

What securities did SRXH previously sell to accredited investors in August 2026?

On August 27, 2026, SRX Global sold 3,579 shares of its Series C convertible preferred stock to accredited investors for an aggregate purchase price of $2.825 million, under a Securities Purchase Agreement.

Does SRXH’s Series C preferred stock convert into common stock?

Yes. The filing states that the Series C convertible preferred stock is convertible into shares of SRX Global’s common stock, though specific conversion terms are not detailed in this summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 03:00 PM Accepted by SEC EDGAR 09/09/2026 - 03:00 PM Learn about SEC filing dates

false 0001471727 0001471727 2026-09-08 2026-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 8, 2026

SRX Global Inc.

(Exact name of Registrant as Specified in its Charter)

Delaware		001-40477		83-4284557
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

801 US Highway 1

North Palm Beach, Florida 33408

(Address of Principal Executive Offices) (Zip Code)

(Registrant’s Telephone Number, Including Area Code): (212) 896-1254

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value share		SRXH		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

As previously disclosed, on August 27, 2026, SRX Global Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors (“Buyers”) named therein, pursuant to which, among other things, the Buyers purchased 3,579 shares of the Company’s Series C convertible preferred stock, par value $0.001 per share (the “Series C Preferred Stock”), which are convertible into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for an aggregate purchase price of $2.825 million.

On September 8, 2026, the Company and the Required Holders entered into a Limited Consent and Amendment Agreement (the “Consent Agreement”), pursuant to which the Required Holders (as defined in the Securities Purchase Agreement, as amended by the Consent Agreement) consented to, and waived certain rights in connection with, the Company’s maintaining a stock repurchase plan under which the Company may repurchase up to the lesser of (x) 10,000,000 shares of Common Stock, or (y) 50% of the issued and outstanding Common Stock at any given time, for an aggregate purchase price not to exceed $20,000,000, during the period ending July 7, 2027.

The foregoing description of the terms and conditions of the Consent Agreement does not purport to be complete and is qualified in its entirety by the full text of the form of Consent Agreement, which is filed as an exhibit thereto.

Item 9.01. Exhibits.

(d) Exhibits.

Exhibits		Description
10.1		Limited Consent and Amendment Agreement.
104		Cover Page Interactive Data File (Embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SRX Global Inc.
	By:	/s/ Carolina Martinez
	Name:	Carolina Martinez
	Title:	Chief Financial Officer
September 9, 2026

Filing Exhibits & Attachments

4 documents

Agreements & Contracts

• EX-10.1 EX-10.1 30.6 KB

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB